Neoquine Syrup

About Neoquine 80 mg/5 ml Syrup

Neoquine is a chloroquine phosphate syrup used to treat and prevent malaria and certain other conditions. It belongs to a group of anti-malarial medicines and is available as an 80 mg/5 ml syrup.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Neoquine 80 mg/5 ml Syrup?

Neoquine Syrup contains chloroquine phosphate, an anti-malarial medicine. It is used to treat malaria attacks, to prevent malaria, and to treat amoebic hepatitis and abscess. It is also used in some inflammatory conditions such as discoid and systemic lupus erythematosus and rheumatoid arthritis. The syrup is available in an 80 mg/5 ml strength. Chloroquine works against the malaria parasite in the blood and also has effects in other conditions. Treatment should be prescribed and supervised by a doctor, who will decide the appropriate dose and course for each person.

Uses of Neoquine

Neoquine Syrup is used to treat malaria and to prevent it. It is also used to treat amoebic hepatitis and amoebic abscess, and in some patients with discoid or systemic lupus erythematosus or rheumatoid arthritis. Only a doctor can decide whether this medicine is suitable for a particular person and condition.

How to use Neoquine

Neoquine Syrup is taken by mouth. The doctor decides the dose, how often it is taken, and how long the course lasts, based on the condition being treated, the person's age and other factors. Follow the doctor's instructions exactly. If a dose is missed or symptoms change, ask the doctor or pharmacist for advice.

Side effects of Neoquine

At standard doses, chloroquine is usually well tolerated. Some people may have headache or stomach upset, which are not usually serious. With prolonged high doses, more serious effects can occur, including skin rashes, hair loss, difficulty focusing the eyes, blurred vision, and rarely blood problems. Long-term use carries a risk of eye damage. Tell your doctor about any side effect.

Safety and precautions

Before taking Neoquine Syrup, tell your doctor if you have liver problems, porphyria, or eye problems, or if you drink alcohol regularly. The medicine may interact with other drugs, so mention all medicines you take. Use in pregnancy should be avoided if possible unless the doctor decides the benefit outweighs the risk. People who need long-term treatment may need eye checks as advised by the doctor. Always ask your doctor or pharmacist if you are unsure whether this medicine is right for you.

Frequently asked questions

What is Neoquine Syrup used for and what kind of medicine is it?

Neoquine Syrup is an anti-malarial medicine. It is used to treat malaria and to prevent it, and also to treat amoebic hepatitis and abscess. It may be used in some other conditions such as lupus and rheumatoid arthritis, as decided by a doctor.

How should Neoquine Syrup be taken?

It is taken by mouth. The doctor decides the dose, how often to take it, and how long the course should be, based on the condition and the person. Always follow the doctor's instructions and ask the doctor or pharmacist if you are unsure.

What does the generic name chloroquine phosphate mean?

Chloroquine phosphate is the active ingredient in Neoquine Syrup. It is an anti-malarial medicine that works against the malaria parasite in the blood. The generic name refers to the chemical substance itself, not to the brand.

Can Neoquine Syrup be used during pregnancy?

The use of chloroquine during pregnancy should be avoided if possible, unless the doctor decides that the potential benefit outweighs the risk in case of a threatening infection. Ask your doctor before taking this medicine if you are pregnant or planning pregnancy.

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.